Anette Kocbach Bølling
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anette Kocbach Bølling has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Per Everhard Schwarze
Norwegian Inst Publ Hlth, Oslo, Norway
3 shared publications - Rune Becher
Domain of Infection Control and Environmental Health, Norwegian Institute of Public Health, P.O. Box 4404 Nydalen, N-0403 Oslo, Norway
3 shared publications - Gerd Sallsten
Occupational and Environmental Medicine, Sahlgrenska University Hospital and University of Gothenburg, SE 413 45 Gothenburg, Sweden
2 shared publications - Johanna Bodin
Section of Immunology, Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway
2 shared publications Per E. Schwarze
Division of Environmental Medicine, Norwegian Institute of Public Health, Geitemyrsveien 75, 0462 Oslo, Norway
2 shared publicationsRune Becher
Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
2 shared publications
Latest Publications
- Open Access
- 11 December 2025
- Published by Springer Nature in Environmental Health
- Vol. 25 (1)
Burden of disease attributable to PM2.5 at low exposure levels: impact of methodological choices
Background: Exposure to fine particles (PM 2.5 ) has been associated with adverse health outcomes, even at low exposure levels (< 10 µg/m 3 ). Burden of disease assessments can quantify these associations; however, their sensitivity to methodological choices limits comparability between studies. Methods: This study aimed to quantify the impact of methodological choices on disease burden attributable to low levels of ambient PM 2.5 , using Norway as a case study. Key methodological choices included (i) population exposure data, (ii) concentration-response curves, and (iii) population health data. Data from national and international sources were applied, including the global burden of disease (GBD) study. Attributable mortality and disability-adjusted life years (DALY) were estimated using burden of disease methodology. Additionally, the impact of choices related to concentration-response curves was assessed for higher exposure levels, using a scenario where exposure distributions were shifted to mean exposures up to 30 µg/m 3 . Results: Methodological choices related to the concentration-response curves had the largest impacts on the estimated attributable deaths, ranging from − 91% to 104% change relative to the reference estimate (1,448 deaths, 95% CI 502–1497). These choices had a smaller impact on higher exposure levels, varying from − 46% to 53%. The choice of exposure and population health data led to 40% differences in attributable death estimates. DALYs attributable to PM 2.5 were predominantly driven by years of life lost (YLL: 74%). The choice of relative risk (RR) for the concentration response curve caused around 30% variation in DALY estimates relative to the reference (11,730 DALYs; 5,980 − 16,790), with larger differences for ischemic heart disease (-44 to 79%). Conclusion: Attributable burden estimates for PM 2.5 are highly sensitive to key methodological choices, particularly at low exposure levels. Consequently, transparent reporting of the methodological choices and data sources in PM 2.5 health risk assessments are required to improve comparability and facilitate interpretations of the burden estimates.
- 11 December 2025
- Published by Springer Nature in Environmental Health
- Vol. 25 (1)
Open AccessBurden of disease attributable to PM2.5 at low exposure levels: impact of methodological choices
Background: Exposure to fine particles (PM 2.5 ) has been associated with adverse health outcomes, even at low exposure levels (< 10 µg/m 3 ). Burden of disease assessments can quantify these associations; however, their sensitivity to methodological choices limits comparability between studies. Methods: This study aimed to quantify the impact of methodological choices on disease burden attributable to low levels of ambient PM 2.5 , using Norway as a case study. Key methodological choices included (i) population exposure data, (ii) concentration-response curves, and (iii) population health data. Data from national and international sources were applied, including the global burden of disease (GBD) study. Attributable mortality and disability-adjusted life years (DALY) were estimated using burden of disease methodology. Additionally, the impact of choices related to concentration-response curves was assessed for higher exposure levels, using a scenario where exposure distributions were shifted to mean exposures up to 30 µg/m 3 . Results: Methodological choices related to the concentration-response curves had the largest impacts on the estimated attributable deaths, ranging from − 91% to 104% change relative to the reference estimate (1,448 deaths, 95% CI 502–1497). These choices had a smaller impact on higher exposure levels, varying from − 46% to 53%. The choice of exposure and population health data led to 40% differences in attributable death estimates. DALYs attributable to PM 2.5 were predominantly driven by years of life lost (YLL: 74%). The choice of relative risk (RR) for the concentration response curve caused around 30% variation in DALY estimates relative to the reference (11,730 DALYs; 5,980 − 16,790), with larger differences for ischemic heart disease (-44 to 79%). Conclusion: Attributable burden estimates for PM 2.5 are highly sensitive to key methodological choices, particularly at low exposure levels. Consequently, transparent reporting of the methodological choices and data sources in PM 2.5 health risk assessments are required to improve comparability and facilitate interpretations of the burden estimates.
- Open Access
- 1 June 2020
- Published by Elsevier in Environment International
- Vol. 139, 105706
Phthalate exposure and allergic diseases: Review of epidemiological and experimental evidence
- 1 June 2020
- Published by Elsevier in Environment International
- Vol. 139, 105706
Open AccessPhthalate exposure and allergic diseases: Review of epidemiological and experimental evidence
- 1 January 2019
- Published by Elsevier in Dental Materials
- Vol. 35 (1) , 125-134
The dental monomer 2-hydroxyethyl methacrylate (HEMA) causes transcriptionally regulated adaptation partially initiated by electrophilic stress
- 1 January 2019
- Published by Elsevier in Dental Materials
- Vol. 35 (1) , 125-134
The dental monomer 2-hydroxyethyl methacrylate (HEMA) causes transcriptionally regulated adaptation partially initiated by electrophilic stress
- 1 September 2016
- Published by Elsevier in Toxicology Letters
- Vol. 258, S25
Exposure to endocrine disruptors accelerates diabetes type 1 development in NOD mice via impaired macrophage function
- 1 September 2016
- Published by Elsevier in Toxicology Letters
- Vol. 258, S25
Exposure to endocrine disruptors accelerates diabetes type 1 development in NOD mice via impaired macrophage function
- 1 September 2015
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 83, 17-25
Early life exposure to bisphenol A investigated in mouse models of airway allergy, food allergy and oral tolerance
- 1 September 2015
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 83, 17-25
Early life exposure to bisphenol A investigated in mouse models of airway allergy, food allergy and oral tolerance
- 20 August 2013
- Vol. 12, 733-59
Pulmonary phthalate exposure and asthma - is PPAR a plausible mechanistic link?
Due to their extensive use as plasticisers in numerous consumer products, phthalates have become ubiquitous environmental contaminants. An increasing number of epidemiological studies suggest that exposure to phthalates may be associated with worsening or development of airway diseases. Peroxisome Proliferation Activated Receptors (PPAR)s, identified as important targets for phthalates in early studies in rodent liver, have been suggested as a possible mechanistic link. In this review we discuss the likelihood of an involvement of PPARs in asthma development and exacerbation due to pulmonary phthalate exposure. First, we go through the literature on indoor air levels of phthalates and pulmonary phthalate kinetics. These data are then used to estimate the pulmonary phthalate levels due to inhalation exposure. Secondly, the literature on phthalate-induced activation or modulation of PPARs is summarized. Based on these data, we discuss whether pulmonary phthalate exposure is likely to cause PPAR activation, and if this is a plausible mechanism for adverse effects of phthalates in the lung. It is concluded that the pulmonary concentrations of some phthalates may be sufficient to cause a direct activation of PPARs. Since PPARs mainly mediate anti-inflammatory effects in the lungs, a direct activation is not a likely molecular mechanism for adverse effects of phthalates. However, possible modulatory effects of phthalates on PPARs deserve further investigation, including partial antagonist effects and/or cross talk with other signalling pathways. Moreover other mechanisms, including interactions between phthalates and other receptors, could also contribute to possible adverse pulmonary effects of phthalates.
- 20 August 2013
- Vol. 12, 733-59
Pulmonary phthalate exposure and asthma - is PPAR a plausible mechanistic link?
Due to their extensive use as plasticisers in numerous consumer products, phthalates have become ubiquitous environmental contaminants. An increasing number of epidemiological studies suggest that exposure to phthalates may be associated with worsening or development of airway diseases. Peroxisome Proliferation Activated Receptors (PPAR)s, identified as important targets for phthalates in early studies in rodent liver, have been suggested as a possible mechanistic link. In this review we discuss the likelihood of an involvement of PPARs in asthma development and exacerbation due to pulmonary phthalate exposure. First, we go through the literature on indoor air levels of phthalates and pulmonary phthalate kinetics. These data are then used to estimate the pulmonary phthalate levels due to inhalation exposure. Secondly, the literature on phthalate-induced activation or modulation of PPARs is summarized. Based on these data, we discuss whether pulmonary phthalate exposure is likely to cause PPAR activation, and if this is a plausible mechanism for adverse effects of phthalates in the lung. It is concluded that the pulmonary concentrations of some phthalates may be sufficient to cause a direct activation of PPARs. Since PPARs mainly mediate anti-inflammatory effects in the lungs, a direct activation is not a likely molecular mechanism for adverse effects of phthalates. However, possible modulatory effects of phthalates on PPARs deserve further investigation, including partial antagonist effects and/or cross talk with other signalling pathways. Moreover other mechanisms, including interactions between phthalates and other receptors, could also contribute to possible adverse pulmonary effects of phthalates.
- 1 February 2012
- Published by Elsevier in Toxicology Letters
- Vol. 209 (1) , 43-50
Mono-2-ethylhexylphthalate (MEHP) induces TNF-α release and macrophage differentiation through different signalling pathways in RAW264.7 cells
- 1 February 2012
- Published by Elsevier in Toxicology Letters
- Vol. 209 (1) , 43-50
Mono-2-ethylhexylphthalate (MEHP) induces TNF-α release and macrophage differentiation through different signalling pathways in RAW264.7 cells
- Open Access
- 1 January 2012
- Published by Springer Nature in Particle and Fibre Toxicology
- Vol. 9 (1) , 45
Wood smoke particles from different combustion phases induce similar pro-inflammatory effects in a co-culture of monocyte and pneumocyte cell lines
Exposure to particulate matter (PM) has been linked to several adverse cardiopulmonary effects, probably via biological mechanisms involving inflammation. The pro-inflammatory potential of PM depends on the particles’ physical and chemical characteristics, which again depend on the emitting source. Wood combustion is a major source of ambient air pollution in Northern countries during the winter season. The overall aim of this study was therefore to investigate cellular responses to wood smoke particles (WSPs) collected from different phases of the combustion cycle, and from combustion at different temperatures.
- 1 January 2012
- Published by Springer Nature in Particle and Fibre Toxicology
- Vol. 9 (1) , 45
Open AccessWood smoke particles from different combustion phases induce similar pro-inflammatory effects in a co-culture of monocyte and pneumocyte cell lines
Exposure to particulate matter (PM) has been linked to several adverse cardiopulmonary effects, probably via biological mechanisms involving inflammation. The pro-inflammatory potential of PM depends on the particles’ physical and chemical characteristics, which again depend on the emitting source. Wood combustion is a major source of ambient air pollution in Northern countries during the winter season. The overall aim of this study was therefore to investigate cellular responses to wood smoke particles (WSPs) collected from different phases of the combustion cycle, and from combustion at different temperatures.
- Open Access
- 6 November 2009
- Published by Springer Nature in Particle and Fibre Toxicology
- Vol. 6 (1) , 29
Health effects of residential wood smoke particles: the importance of combustion conditions and physicochemical particle properties
Background: Residential wood combustion is now recognized as a major particle source in many developed countries, and the number of studies investigating the negative health effects associated with wood smoke exposure is currently increasing. The combustion appliances in use today provide highly variable combustion conditions resulting in large variations in the physicochemical characteristics of the emitted particles. These differences in physicochemical properties are likely to influence the biological effects induced by the wood smoke particles. Outline: The focus of this review is to discuss the present knowledge on physicochemical properties of wood smoke particles from different combustion conditions in relation to wood smoke-induced health effects. In addition, the human wood smoke exposure in developed countries is explored in order to identify the particle characteristics that are relevant for experimental studies of wood smoke-induced health effects. Finally, recent experimental studies regarding wood smoke exposure are discussed with respect to the applied combustion conditions and particle properties. Conclusion: Overall, the reviewed literature regarding the physicochemical properties of wood smoke particles provides a relatively clear picture of how these properties vary with the combustion conditions, whereas particle emissions from specific classes of combustion appliances are less well characterised. The major gaps in knowledge concern; (i) characterisation of the atmospheric transformations of wood smoke particles, (ii) characterisation of the physicochemical properties of wood smoke particles in ambient and indoor environments, and (iii) identification of the physicochemical properties that influence the biological effects of wood smoke particles.
- 6 November 2009
- Published by Springer Nature in Particle and Fibre Toxicology
- Vol. 6 (1) , 29
Open AccessHealth effects of residential wood smoke particles: the importance of combustion conditions and physicochemical particle properties
Background: Residential wood combustion is now recognized as a major particle source in many developed countries, and the number of studies investigating the negative health effects associated with wood smoke exposure is currently increasing. The combustion appliances in use today provide highly variable combustion conditions resulting in large variations in the physicochemical characteristics of the emitted particles. These differences in physicochemical properties are likely to influence the biological effects induced by the wood smoke particles. Outline: The focus of this review is to discuss the present knowledge on physicochemical properties of wood smoke particles from different combustion conditions in relation to wood smoke-induced health effects. In addition, the human wood smoke exposure in developed countries is explored in order to identify the particle characteristics that are relevant for experimental studies of wood smoke-induced health effects. Finally, recent experimental studies regarding wood smoke exposure are discussed with respect to the applied combustion conditions and particle properties. Conclusion: Overall, the reviewed literature regarding the physicochemical properties of wood smoke particles provides a relatively clear picture of how these properties vary with the combustion conditions, whereas particle emissions from specific classes of combustion appliances are less well characterised. The major gaps in knowledge concern; (i) characterisation of the atmospheric transformations of wood smoke particles, (ii) characterisation of the physicochemical properties of wood smoke particles in ambient and indoor environments, and (iii) identification of the physicochemical properties that influence the biological effects of wood smoke particles.
- 1 October 2008
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 232 (2) , 317-326
Particles from wood smoke and traffic induce differential pro-inflammatory response patterns in co-cultures
- 1 October 2008
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 232 (2) , 317-326
Particles from wood smoke and traffic induce differential pro-inflammatory response patterns in co-cultures